Jeffrey T. L. Smith, Senior VP Translational Medicine at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 6,000 shares at $30.99 ($187K) on 2016-10-03, disclosed to the SEC on 2016-10-05.
Open-market sale of $187k ALDR by Senior VP Translational Medicine. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.99 | 2,298 | $71K | 38.1% |
| 2 | $30.99 | 2,298 | $71K | 38.1% |
| 3 | $31.62 | 702 | $22K | 11.9% |
| 4 | $31.62 | 702 | $22K | 11.9% |
| Total | $31.14 avg | 6,000 | $187K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |